
PTC Therapeutics, Inc. (NASDAQ:PTCT) Surging on Positive CF Drug Results
Boston, MA 05/23/2014 (wallstreetpr) – Biopharmaceutical Company, PTC Therapeutics, Inc. (NASDAQ: PTCT), is surging by as much as 72.43% after the Committee for Medicinal Products












